← All companies
About this company
OUR PURPOSE Kuros Biosciences is on a mission to discover, develop and deliver innovative biologic technologies. OUR CREDENTIALS Kuros is a Swiss-headquartered biotech company, listed on the SIX Swiss Stock Exchange since 2016 (under symbol KURN). With additional operations in the Netherlands and the USA, we continue to grow our global team. To deliver the ideal bone graft, you need the highest quality and quantity of scientific evidence behind it. We believe that this is a key differentiator for Kuros, given the urgent need to advance bone healing. • Listing on the 𝗦𝗜𝗫 𝗦𝘄𝗶𝘀𝘀 𝗘𝘅𝗰𝗵𝗮𝗻𝗴𝗲 under the symbol KURN since 2016 • A commercial & research footprint that spans >𝟮𝟬 𝗺𝗮𝗿𝗸𝗲𝘁𝘀 • Dozens of 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗮𝗻𝗱 𝘀𝗰𝗶𝗲𝗻𝘁𝗶𝗳𝗶𝗰 𝗲𝘅𝗽𝗲𝗿𝘁 𝗮𝗱𝘃𝗶𝘀𝗲𝗿𝘀 • >𝟮𝟱 orthobiologics-related 𝗽𝗮𝘁𝗲𝗻𝘁𝘀 • >𝟰𝟬𝟬 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝗲𝘃𝗮𝗹𝘂𝗮𝘁𝗲𝗱 in Level I, randomized controlled clinical trials • >𝟮𝟬 well-controlled 𝗟𝗲𝘃𝗲𝗹 𝗜-𝗜𝗩 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹𝘀 𝗶𝗻𝗶𝘁𝗶𝗮𝘁𝗲𝗱, including 6 that are complete¹ • Published Level I evidence published in 𝑆𝑝𝑖𝑛𝑒 CONTACT KUROS TO FIND OUT MORE >>>>